Letters

Ethnic differences in risks of adverse reactions: Is personalised drug treatment better with pharmacokinetic modelling?

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7554.1393 (Published 08 June 2006) Cite this as: BMJ 2006;332:1393
  1. David S Millson (david.millson@tiscali.co.uk), general practitioner principal
  1. Leek Health Centre, Leek ST13 6JB

    EDITOR—McDowell et al conclude that patients from different ethnic groups have different risks for important adverse drug reactions on the basis of a meta-analysis of adverse reactions due to drugs used in cardiovascular medicine.1 Data are sparse, and regulators should ask for better …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe